These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23750677)

  • 41. Chronic activation of the baroreflex and the promise for hypertension therapy.
    Lohmeier TE; Iliescu R
    Handb Clin Neurol; 2013; 117():395-406. PubMed ID: 24095142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lowering of blood pressure during chronic suppression of central sympathetic outflow: insight from computer simulations.
    Iliescu R; Lohmeier TE
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e24-33. PubMed ID: 19769610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrical stimulation of the carotid sinus for the treatment of resistant hypertension.
    Filippone JD; Sloand JA; Illig KA; Bisognano JD
    Curr Hypertens Rep; 2006 Oct; 8(5):420-4. PubMed ID: 16965730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation.
    Lohmeier TE; Iliescu R
    J Appl Physiol (1985); 2012 Nov; 113(10):1652-8. PubMed ID: 22797307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].
    Koziolek M; Beige J; Wallbach M; Zenker D; Henning G; Halbach M; Mader N; Mahfoud F; Schlieper G; Schwenger V; Hausberg M; Börgel J; Lodde M; van der Giet M; Müller-Ehmsen J; Passauer J; Parmentier S; Lüders S; Krämer BK; Büttner S; Limbourg F; Jordan J; Vonend O; Predel HG; Reuter H
    Internist (Berl); 2017 Oct; 58(10):1114-1123. PubMed ID: 28835975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arterial baroreceptors in the management of systemic hypertension.
    Kougias P; Weakley SM; Yao Q; Lin PH; Chen C
    Med Sci Monit; 2010 Jan; 16(1):RA1-8. PubMed ID: 20037502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?
    Doumas M
    Curr Vasc Pharmacol; 2014 Jan; 12(1):2-3. PubMed ID: 23905600
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of nonpharmacologic device interventions in the management of drug-resistant hypertension.
    Frishman WH; Glicklich D
    Curr Atheroscler Rep; 2014 May; 16(5):405. PubMed ID: 24623177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Resistant hypertension and carotid baroreceptors stimulation].
    Lantelme P; Harbaoui B; Courand PY
    Presse Med; 2015; 44(7-8):730-6. PubMed ID: 26144275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug-independent blood pressure control through the autonomous nervous system].
    Schmidli J; Mohaupt MG
    Ther Umsch; 2012 May; 69(5):325-9. PubMed ID: 22547365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
    Spiering W; Williams B; Van der Heyden J; van Kleef M; Lo R; Versmissen J; Moelker A; Kroon A; Reuter H; Ansel G; Stone GW; Bates M;
    Lancet; 2017 Dec; 390(10113):2655-2661. PubMed ID: 28870716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral or unilateral stimulation for baroreflex activation therapy.
    de Leeuw PW; Alnima T; Lovett E; Sica D; Bisognano J; Haller H; Kroon AA
    Hypertension; 2015 Jan; 65(1):187-92. PubMed ID: 25331845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baroreflex activation therapy in hypertension.
    Gassler JP; Bisognano JD
    J Hum Hypertens; 2014 Aug; 28(8):469-74. PubMed ID: 24477209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel approaches: targeting sympathetic outflow in the carotid sinus.
    Hering D; Narkiewicz K
    Blood Press; 2023 Dec; 32(1):2232873. PubMed ID: 37470450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Device Therapy of Hypertension.
    Mahfoud F; Schlaich MP; Lobo MD
    Circ Res; 2021 Apr; 128(7):1080-1099. PubMed ID: 33793330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Baroflex stimulation: a novel treatment option for resistant hypertension].
    Eckert S
    MMW Fortschr Med; 2011 Feb; 153(6):49-50. PubMed ID: 21644339
    [No Abstract]   [Full Text] [Related]  

  • 57. Baroreflex device therapy in the treatment of hypertension.
    Uppuluri SC; Storozynsky E; Bisognano JD
    Curr Hypertens Rep; 2009 Feb; 11(1):69-75. PubMed ID: 19146804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.
    Chobanyan-Jürgens K; Jordan J
    Curr Hypertens Rep; 2015 Sep; 17(9):587. PubMed ID: 26208917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Device profile of the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy.
    Bates MC; Stone GW; Chen CY; Spiering W
    Expert Rev Med Devices; 2020 Jul; 17(7):649-658. PubMed ID: 32510250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Device treatment approaches targeting the sympathetic nervous system in patients with resistant hypertension].
    Okuyama Y; Sakata Y
    Nihon Rinsho; 2015 Nov; 73(11):1857-63. PubMed ID: 26619659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.